Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life among Individuals with Alcohol Use Disorder

BACKGROUND. Abstinence and no heavy drinking days are currently the only Food and Drug Administration (FDA) approved endpoints in clinical trials for alcohol use disorder (AUD). Many individuals who fail to meet these criteria may substantially reduce their drinking during treatment and most individ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alcohol Clin Exp Res
Main Authors: Witkiewitz, Katie, Kranzler, Henry R., Hallgren, Kevin A., O’Malley, Stephanie S., Falk, Daniel E., Litten, Raye Z., Hasin, Deborah S., Mann, Karl F., Anton, Raymond F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6286196/
https://ncbi.nlm.nih.gov/pubmed/30395350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acer.13897
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados